Etoricoxib pre-medication combined with intra-operative subacromial block for pain after arthroscopic acromioplasty

Background:  Arthroscopic shoulder surgery under general anaesthesia is often associated with severe post‐operative pain which may delay discharge and the start of rehabilitation. Etoricoxib is a new cyclo‐oxygenase‐2 inhibitor with a long duration of action and a lack of a deteriorating effect on p...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Acta anaesthesiologica Scandinavica 2007-03, Vol.51 (3), p.316-321
Hauptverfasser: Toivonen, J., Pitko, V.-M., Rosenberg, P. H.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 321
container_issue 3
container_start_page 316
container_title Acta anaesthesiologica Scandinavica
container_volume 51
creator Toivonen, J.
Pitko, V.-M.
Rosenberg, P. H.
description Background:  Arthroscopic shoulder surgery under general anaesthesia is often associated with severe post‐operative pain which may delay discharge and the start of rehabilitation. Etoricoxib is a new cyclo‐oxygenase‐2 inhibitor with a long duration of action and a lack of a deteriorating effect on platelet function. Therefore, the effect of pre‐operative etoricoxib combined with local anaesthesia on post‐operative pain and the discharge profile was studied in day‐surgery patients undergoing arthroscopic shoulder surgery under general anaesthesia. Methods:  Thirty ASA I–II adult patients scheduled for arthroscopic shoulder surgery were enrolled in this randomized prospective study. Half of the patients received etoricoxib 120 mg orally (group E) and the other half received placebo tablet orally (group C) 1 h before surgery. All patients received 20 ml of bupivacaine 2.5 mg/ml solution with epinephrine at the start of surgery and 20 ml of bupivacaine 5.0 mg/ml solution with epinephrine at the end of surgery into the subacromial space. All patients received general anaesthesia with spontaneous breathing via a laryngeal mask. In the post‐anaesthesia care unit, pain was assessed on a scale from 0 to 10 (visual analogue scale, VAS) and intravenous fentanyl 25 μg was administered as scheduled (VAS ≥ 3). In the day‐surgery unit and at home, the analgesic was a tablet containing paracetamol 500 mg + codeine 30 mg (VAS ≥ 3), as needed. Results:  Patients in group E reported lower post‐operative pain scores at 30, 60, 120 (P < 0.01) and 180 min (P < 0.05) after surgery, and longer time to first analgesic use (P < 0.05). Patients in group E required less fentanyl (P < 0.05) and were discharged more quickly (P < 0.05) than patients in group C. Patients in group E had a lower cumulative consumption of paracetamol + codeine tablets (P < 0.05) and lower pain scores (P < 0.05) during 7 days at home than patients in group C. Adverse events were rare in both groups. Conclusion:  In patients having arthroscopic shoulder surgery under general anaesthesia combined with intra‐operative subacromial regional analgesia, etoricoxib 120 mg reduced immediate and late post‐operative pain, and facilitated early post‐operative discharge.
doi_str_mv 10.1111/j.1399-6576.2006.01204.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69031950</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>69031950</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4604-92a2505743e0d698d44903e5f487012fd08a155055f28554149a889404b5acad3</originalsourceid><addsrcrecordid>eNqNkMFu3CAQhlHVqNmmfYWKS3uzAzbYcOhhFaVp1SiVklapekFjjBU2tnGAbXbfvjheJddyAcT3DzMfQpiSnKZ1uslpKWVW8brKC0KqnNCCsHz3Cq2eH16jFSGEZpzWxTF6G8ImXUsm5Rt0TGvKuSzrFQrn0Xmr3c42ePImG0xrNUTrRqzd0NjRtPjRxjtsx-ghc5Px6fWvwWHbgPZusNDjpnf6HnfO4wnsiKGLxmPw8c67oN1kNV5QN_UQ4v4dOuqgD-b9YT9Bv76c_zz7ml3-uPh2tr7MNKsIy2QBBSe8ZqUhbSVFy5gkpeEdE3Wat2uJgDQG4bwrBOeMMglCSEZYw0FDW56gT0vdybuHrQlRDTZo0_cwGrcNqkrlqOQkgWIBU5cheNOpydsB_F5RombhaqNmr2r2qmbh6km42qXoh8Mf2ya5ewkeDCfg4wGAoKHvPIzahhdOcFaKqkjc54V7tL3Z_3cDar2-mU8pny15G6LZPefB36uqLmuubq8uFP_N6Pfba6H-lP8AWT-sFA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69031950</pqid></control><display><type>article</type><title>Etoricoxib pre-medication combined with intra-operative subacromial block for pain after arthroscopic acromioplasty</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Toivonen, J. ; Pitko, V.-M. ; Rosenberg, P. H.</creator><creatorcontrib>Toivonen, J. ; Pitko, V.-M. ; Rosenberg, P. H.</creatorcontrib><description><![CDATA[Background:  Arthroscopic shoulder surgery under general anaesthesia is often associated with severe post‐operative pain which may delay discharge and the start of rehabilitation. Etoricoxib is a new cyclo‐oxygenase‐2 inhibitor with a long duration of action and a lack of a deteriorating effect on platelet function. Therefore, the effect of pre‐operative etoricoxib combined with local anaesthesia on post‐operative pain and the discharge profile was studied in day‐surgery patients undergoing arthroscopic shoulder surgery under general anaesthesia. Methods:  Thirty ASA I–II adult patients scheduled for arthroscopic shoulder surgery were enrolled in this randomized prospective study. Half of the patients received etoricoxib 120 mg orally (group E) and the other half received placebo tablet orally (group C) 1 h before surgery. All patients received 20 ml of bupivacaine 2.5 mg/ml solution with epinephrine at the start of surgery and 20 ml of bupivacaine 5.0 mg/ml solution with epinephrine at the end of surgery into the subacromial space. All patients received general anaesthesia with spontaneous breathing via a laryngeal mask. In the post‐anaesthesia care unit, pain was assessed on a scale from 0 to 10 (visual analogue scale, VAS) and intravenous fentanyl 25 μg was administered as scheduled (VAS ≥ 3). In the day‐surgery unit and at home, the analgesic was a tablet containing paracetamol 500 mg + codeine 30 mg (VAS ≥ 3), as needed. Results:  Patients in group E reported lower post‐operative pain scores at 30, 60, 120 (P < 0.01) and 180 min (P < 0.05) after surgery, and longer time to first analgesic use (P < 0.05). Patients in group E required less fentanyl (P < 0.05) and were discharged more quickly (P < 0.05) than patients in group C. Patients in group E had a lower cumulative consumption of paracetamol + codeine tablets (P < 0.05) and lower pain scores (P < 0.05) during 7 days at home than patients in group C. Adverse events were rare in both groups. Conclusion:  In patients having arthroscopic shoulder surgery under general anaesthesia combined with intra‐operative subacromial regional analgesia, etoricoxib 120 mg reduced immediate and late post‐operative pain, and facilitated early post‐operative discharge.]]></description><identifier>ISSN: 0001-5172</identifier><identifier>EISSN: 1399-6576</identifier><identifier>DOI: 10.1111/j.1399-6576.2006.01204.x</identifier><identifier>PMID: 17155937</identifier><identifier>CODEN: AANEAB</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Adult ; Anesthesia ; Anesthesia, General ; Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; Anesthetics, Local ; arthroscopic shoulder surgery ; Arthroscopy ; Biological and medical sciences ; Combined Modality Therapy ; Cyclooxygenase Inhibitors - therapeutic use ; day surgery ; Double-Blind Method ; etoricoxib ; Female ; general anaesthesia ; Humans ; Male ; Medical sciences ; Middle Aged ; Nerve Block ; Pain Measurement - methods ; Pain, Postoperative - drug therapy ; post-operative pain ; Preanesthetic Medication - methods ; Prospective Studies ; Pyridines - therapeutic use ; Shoulder Joint - surgery ; Sulfones - therapeutic use ; Time Factors</subject><ispartof>Acta anaesthesiologica Scandinavica, 2007-03, Vol.51 (3), p.316-321</ispartof><rights>2006 Acta Anaesthesiol Scand</rights><rights>2007 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4604-92a2505743e0d698d44903e5f487012fd08a155055f28554149a889404b5acad3</citedby><cites>FETCH-LOGICAL-c4604-92a2505743e0d698d44903e5f487012fd08a155055f28554149a889404b5acad3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1399-6576.2006.01204.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1399-6576.2006.01204.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=18543862$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17155937$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Toivonen, J.</creatorcontrib><creatorcontrib>Pitko, V.-M.</creatorcontrib><creatorcontrib>Rosenberg, P. H.</creatorcontrib><title>Etoricoxib pre-medication combined with intra-operative subacromial block for pain after arthroscopic acromioplasty</title><title>Acta anaesthesiologica Scandinavica</title><addtitle>Acta Anaesthesiol Scand</addtitle><description><![CDATA[Background:  Arthroscopic shoulder surgery under general anaesthesia is often associated with severe post‐operative pain which may delay discharge and the start of rehabilitation. Etoricoxib is a new cyclo‐oxygenase‐2 inhibitor with a long duration of action and a lack of a deteriorating effect on platelet function. Therefore, the effect of pre‐operative etoricoxib combined with local anaesthesia on post‐operative pain and the discharge profile was studied in day‐surgery patients undergoing arthroscopic shoulder surgery under general anaesthesia. Methods:  Thirty ASA I–II adult patients scheduled for arthroscopic shoulder surgery were enrolled in this randomized prospective study. Half of the patients received etoricoxib 120 mg orally (group E) and the other half received placebo tablet orally (group C) 1 h before surgery. All patients received 20 ml of bupivacaine 2.5 mg/ml solution with epinephrine at the start of surgery and 20 ml of bupivacaine 5.0 mg/ml solution with epinephrine at the end of surgery into the subacromial space. All patients received general anaesthesia with spontaneous breathing via a laryngeal mask. In the post‐anaesthesia care unit, pain was assessed on a scale from 0 to 10 (visual analogue scale, VAS) and intravenous fentanyl 25 μg was administered as scheduled (VAS ≥ 3). In the day‐surgery unit and at home, the analgesic was a tablet containing paracetamol 500 mg + codeine 30 mg (VAS ≥ 3), as needed. Results:  Patients in group E reported lower post‐operative pain scores at 30, 60, 120 (P < 0.01) and 180 min (P < 0.05) after surgery, and longer time to first analgesic use (P < 0.05). Patients in group E required less fentanyl (P < 0.05) and were discharged more quickly (P < 0.05) than patients in group C. Patients in group E had a lower cumulative consumption of paracetamol + codeine tablets (P < 0.05) and lower pain scores (P < 0.05) during 7 days at home than patients in group C. Adverse events were rare in both groups. Conclusion:  In patients having arthroscopic shoulder surgery under general anaesthesia combined with intra‐operative subacromial regional analgesia, etoricoxib 120 mg reduced immediate and late post‐operative pain, and facilitated early post‐operative discharge.]]></description><subject>Adult</subject><subject>Anesthesia</subject><subject>Anesthesia, General</subject><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>Anesthetics, Local</subject><subject>arthroscopic shoulder surgery</subject><subject>Arthroscopy</subject><subject>Biological and medical sciences</subject><subject>Combined Modality Therapy</subject><subject>Cyclooxygenase Inhibitors - therapeutic use</subject><subject>day surgery</subject><subject>Double-Blind Method</subject><subject>etoricoxib</subject><subject>Female</subject><subject>general anaesthesia</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Nerve Block</subject><subject>Pain Measurement - methods</subject><subject>Pain, Postoperative - drug therapy</subject><subject>post-operative pain</subject><subject>Preanesthetic Medication - methods</subject><subject>Prospective Studies</subject><subject>Pyridines - therapeutic use</subject><subject>Shoulder Joint - surgery</subject><subject>Sulfones - therapeutic use</subject><subject>Time Factors</subject><issn>0001-5172</issn><issn>1399-6576</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkMFu3CAQhlHVqNmmfYWKS3uzAzbYcOhhFaVp1SiVklapekFjjBU2tnGAbXbfvjheJddyAcT3DzMfQpiSnKZ1uslpKWVW8brKC0KqnNCCsHz3Cq2eH16jFSGEZpzWxTF6G8ImXUsm5Rt0TGvKuSzrFQrn0Xmr3c42ePImG0xrNUTrRqzd0NjRtPjRxjtsx-ghc5Px6fWvwWHbgPZusNDjpnf6HnfO4wnsiKGLxmPw8c67oN1kNV5QN_UQ4v4dOuqgD-b9YT9Bv76c_zz7ml3-uPh2tr7MNKsIy2QBBSe8ZqUhbSVFy5gkpeEdE3Wat2uJgDQG4bwrBOeMMglCSEZYw0FDW56gT0vdybuHrQlRDTZo0_cwGrcNqkrlqOQkgWIBU5cheNOpydsB_F5RombhaqNmr2r2qmbh6km42qXoh8Mf2ya5ewkeDCfg4wGAoKHvPIzahhdOcFaKqkjc54V7tL3Z_3cDar2-mU8pny15G6LZPefB36uqLmuubq8uFP_N6Pfba6H-lP8AWT-sFA</recordid><startdate>200703</startdate><enddate>200703</enddate><creator>Toivonen, J.</creator><creator>Pitko, V.-M.</creator><creator>Rosenberg, P. H.</creator><general>Blackwell Publishing Ltd</general><general>Blackwell</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200703</creationdate><title>Etoricoxib pre-medication combined with intra-operative subacromial block for pain after arthroscopic acromioplasty</title><author>Toivonen, J. ; Pitko, V.-M. ; Rosenberg, P. H.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4604-92a2505743e0d698d44903e5f487012fd08a155055f28554149a889404b5acad3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Adult</topic><topic>Anesthesia</topic><topic>Anesthesia, General</topic><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>Anesthetics, Local</topic><topic>arthroscopic shoulder surgery</topic><topic>Arthroscopy</topic><topic>Biological and medical sciences</topic><topic>Combined Modality Therapy</topic><topic>Cyclooxygenase Inhibitors - therapeutic use</topic><topic>day surgery</topic><topic>Double-Blind Method</topic><topic>etoricoxib</topic><topic>Female</topic><topic>general anaesthesia</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Nerve Block</topic><topic>Pain Measurement - methods</topic><topic>Pain, Postoperative - drug therapy</topic><topic>post-operative pain</topic><topic>Preanesthetic Medication - methods</topic><topic>Prospective Studies</topic><topic>Pyridines - therapeutic use</topic><topic>Shoulder Joint - surgery</topic><topic>Sulfones - therapeutic use</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Toivonen, J.</creatorcontrib><creatorcontrib>Pitko, V.-M.</creatorcontrib><creatorcontrib>Rosenberg, P. H.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Acta anaesthesiologica Scandinavica</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Toivonen, J.</au><au>Pitko, V.-M.</au><au>Rosenberg, P. H.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Etoricoxib pre-medication combined with intra-operative subacromial block for pain after arthroscopic acromioplasty</atitle><jtitle>Acta anaesthesiologica Scandinavica</jtitle><addtitle>Acta Anaesthesiol Scand</addtitle><date>2007-03</date><risdate>2007</risdate><volume>51</volume><issue>3</issue><spage>316</spage><epage>321</epage><pages>316-321</pages><issn>0001-5172</issn><eissn>1399-6576</eissn><coden>AANEAB</coden><abstract><![CDATA[Background:  Arthroscopic shoulder surgery under general anaesthesia is often associated with severe post‐operative pain which may delay discharge and the start of rehabilitation. Etoricoxib is a new cyclo‐oxygenase‐2 inhibitor with a long duration of action and a lack of a deteriorating effect on platelet function. Therefore, the effect of pre‐operative etoricoxib combined with local anaesthesia on post‐operative pain and the discharge profile was studied in day‐surgery patients undergoing arthroscopic shoulder surgery under general anaesthesia. Methods:  Thirty ASA I–II adult patients scheduled for arthroscopic shoulder surgery were enrolled in this randomized prospective study. Half of the patients received etoricoxib 120 mg orally (group E) and the other half received placebo tablet orally (group C) 1 h before surgery. All patients received 20 ml of bupivacaine 2.5 mg/ml solution with epinephrine at the start of surgery and 20 ml of bupivacaine 5.0 mg/ml solution with epinephrine at the end of surgery into the subacromial space. All patients received general anaesthesia with spontaneous breathing via a laryngeal mask. In the post‐anaesthesia care unit, pain was assessed on a scale from 0 to 10 (visual analogue scale, VAS) and intravenous fentanyl 25 μg was administered as scheduled (VAS ≥ 3). In the day‐surgery unit and at home, the analgesic was a tablet containing paracetamol 500 mg + codeine 30 mg (VAS ≥ 3), as needed. Results:  Patients in group E reported lower post‐operative pain scores at 30, 60, 120 (P < 0.01) and 180 min (P < 0.05) after surgery, and longer time to first analgesic use (P < 0.05). Patients in group E required less fentanyl (P < 0.05) and were discharged more quickly (P < 0.05) than patients in group C. Patients in group E had a lower cumulative consumption of paracetamol + codeine tablets (P < 0.05) and lower pain scores (P < 0.05) during 7 days at home than patients in group C. Adverse events were rare in both groups. Conclusion:  In patients having arthroscopic shoulder surgery under general anaesthesia combined with intra‐operative subacromial regional analgesia, etoricoxib 120 mg reduced immediate and late post‐operative pain, and facilitated early post‐operative discharge.]]></abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>17155937</pmid><doi>10.1111/j.1399-6576.2006.01204.x</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0001-5172
ispartof Acta anaesthesiologica Scandinavica, 2007-03, Vol.51 (3), p.316-321
issn 0001-5172
1399-6576
language eng
recordid cdi_proquest_miscellaneous_69031950
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Adult
Anesthesia
Anesthesia, General
Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy
Anesthetics, Local
arthroscopic shoulder surgery
Arthroscopy
Biological and medical sciences
Combined Modality Therapy
Cyclooxygenase Inhibitors - therapeutic use
day surgery
Double-Blind Method
etoricoxib
Female
general anaesthesia
Humans
Male
Medical sciences
Middle Aged
Nerve Block
Pain Measurement - methods
Pain, Postoperative - drug therapy
post-operative pain
Preanesthetic Medication - methods
Prospective Studies
Pyridines - therapeutic use
Shoulder Joint - surgery
Sulfones - therapeutic use
Time Factors
title Etoricoxib pre-medication combined with intra-operative subacromial block for pain after arthroscopic acromioplasty
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T07%3A09%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Etoricoxib%20pre-medication%20combined%20with%20intra-operative%20subacromial%20block%20for%20pain%20after%20arthroscopic%20acromioplasty&rft.jtitle=Acta%20anaesthesiologica%20Scandinavica&rft.au=Toivonen,%20J.&rft.date=2007-03&rft.volume=51&rft.issue=3&rft.spage=316&rft.epage=321&rft.pages=316-321&rft.issn=0001-5172&rft.eissn=1399-6576&rft.coden=AANEAB&rft_id=info:doi/10.1111/j.1399-6576.2006.01204.x&rft_dat=%3Cproquest_cross%3E69031950%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=69031950&rft_id=info:pmid/17155937&rfr_iscdi=true